MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors

TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the appointment of Chris Halyk – former President of Janssen Inc. (Canada), one of the Janssen Pharmaceutical Companies of Johnson & Johnson – to its Board of Directors, effective immediately. This is the third appointment that the Company’s Board has made this year to prepare MediPharm Labs for its next stage of international growth and development.

To read the full press release from MediPharm Labs Corp., click here.

This headline brief is meant to help you stay on the pulse of your favorite cannabis-related companies. Sometimes, just figuring out which marijuana stocks may be moving can be one of the toughest parts of trading and investing in them.

Every day, The Daily Marijuana Observer seeks to keep stakeholders informed with as much of the latest news possible to keep you informed of any catalysts that may impact the companies you care about. Be sure to subscribe to cannabis stock updates here so you never miss a thing.